IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v465y2010i7295d10.1038_nature08971.html
   My bibliography  Save this article

Mutations of optineurin in amyotrophic lateral sclerosis

Author

Listed:
  • Hirofumi Maruyama

    (Research Institute for Radiation Biology and Medicine, Hiroshima University)

  • Hiroyuki Morino

    (Research Institute for Radiation Biology and Medicine, Hiroshima University)

  • Hidefumi Ito

    (Kansai Medical University
    Present address: Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.)

  • Yuishin Izumi

    (University of Tokushima Graduate School)

  • Hidemasa Kato

    (Research Center for Genomic Medicine, Saitama Medical University)

  • Yasuhito Watanabe

    (Laboratory of Integrative Bioscience, Hiroshima University Graduate School of Biomedical Sciences)

  • Yoshimi Kinoshita

    (Kansai Medical University)

  • Masaki Kamada

    (Research Institute for Radiation Biology and Medicine, Hiroshima University
    University of Tokushima Graduate School)

  • Hiroyuki Nodera

    (University of Tokushima Graduate School)

  • Hidenori Suzuki

    (Faculty of Human Science, Hiroshima Bunkyo Women’s University)

  • Osamu Komure

    (South Osaka Neurosurgical Hospital)

  • Shinya Matsuura

    (Research Institute for Radiation Biology and Medicine, Hiroshima University)

  • Keitaro Kobatake

    (Kobatake Hospital)

  • Nobutoshi Morimoto

    (Okayama University, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences)

  • Koji Abe

    (Okayama University, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences)

  • Naoki Suzuki

    (Tohoku University School of Medicine)

  • Masashi Aoki

    (Tohoku University School of Medicine)

  • Akihiro Kawata

    (Tokyo Metropolitan Neurological Hospital, Fuchu, Tokyo 183-0042, Japan)

  • Takeshi Hirai

    (Tokyo Metropolitan Neurological Hospital, Fuchu, Tokyo 183-0042, Japan)

  • Takeo Kato

    (Haematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine)

  • Kazumasa Ogasawara

    (School of Medicine, Shiga University of Medical Science)

  • Asao Hirano

    (Montefiore Medical Center, New York, New York 10467-2490, USA)

  • Toru Takumi

    (Laboratory of Integrative Bioscience, Hiroshima University Graduate School of Biomedical Sciences)

  • Hirofumi Kusaka

    (Kansai Medical University)

  • Koichi Hagiwara

    (Saitama Medical University)

  • Ryuji Kaji

    (University of Tokushima Graduate School)

  • Hideshi Kawakami

    (Research Institute for Radiation Biology and Medicine, Hiroshima University)

Abstract

Optineurin defects in ALS About 10% of cases of the motor neuron disease amyotrophic lateral sclerosis (ALS) are familial, but the small number of mutations so far identified account for only around 20–30% of the those cases. A new study of individuals from ALS-carrying families has now identified three different and previously unknown mutations of OPTN, the gene encoding optineurin. OPTN was earlier reported to be the causative gene of rare familial glaucoma. Optineurin's ability to inhibit activation of the regulatory protein NF-κB is lost in the mutant forms, suggesting that NF-κB inhibitors might be useful in ALS treatment.

Suggested Citation

  • Hirofumi Maruyama & Hiroyuki Morino & Hidefumi Ito & Yuishin Izumi & Hidemasa Kato & Yasuhito Watanabe & Yoshimi Kinoshita & Masaki Kamada & Hiroyuki Nodera & Hidenori Suzuki & Osamu Komure & Shinya M, 2010. "Mutations of optineurin in amyotrophic lateral sclerosis," Nature, Nature, vol. 465(7295), pages 223-226, May.
    • Handle: RePEc:nat:nature:v:465:y:2010:i:7295:d:10.1038_nature08971
    DOI: 10.1038/nature08971
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature08971
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature08971?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:465:y:2010:i:7295:d:10.1038_nature08971. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.